Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Koppel Adam
Relationship:   10% Owner
City:   Boston
State:   MA
   
Insider Summary:
  
   
Companies Owned :   11    
Direct Shares   6,790    

Indirect Shares

   101,509,242      
Direct Value   $694,263    

Indirect Value

   $2,927,222,886      
Total Shares   101,516,032      
Total Value   $2,927,917,150      


Biogen Idec Inc $556,255 Springworks Therapeutics, Inc. $0 Cerevel Therapeutics Holdings, Inc. $138,008 Biogen Idec Inc $556,255 Springworks Therapeutics, Inc. $0 Cerevel Therapeutics Holdings, Inc. $138,008
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    6   
    1    

     Stock price went up :
    4   
    0    
     Stock price went down :
    2   
    1    
   
     Gain/Loss Ratio :
   2.0   
   -1.0   
     Percentage Gain/Loss :
   45.2%
 -14.3%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            PTC Therapeutics, Inc. PTCT Director 2013-06-25 0 2013-06-25 2,333,333    Premium*  
            Biogen Idec Inc BIIB EVP, Strategy and Bus.... 2016-06-06 2,402 2015-06-02 0    Premium*  
            Dicerna Pharmaceuticals Inc DRNA Director 2021-12-28 0 2021-12-28 0    Premium*  
            Marinus Pharmaceuticals Inc MRNS 10% Owner 2017-12-15 0 2017-12-19 3,977,453    Premium*  
            Solid Biosciences Inc SLDB 2018-01-25 0 2024-01-11 4,034,582    Premium*  
            Aptinyx Inc. APTX Director, 10% Owner 2018-06-25 0 2020-10-26 8,891,758    Premium*  
            Replimune Group Inc REPL Director 2018-07-24 0 2018-07-24 2,838,968    Premium*  
            Springworks Therapeutics, Inc. SWTX 10% Owner 2021-08-10 1,106 2021-08-10 4,831,307    Premium*  
            Bcls Acquisition Corp. BLSA Director, 10% Owner 2020-10-26 0 2020-10-26 487,500    Premium*  
            Cerevel Therapeutics Holdings, I... CERE Director, 10% Owner 2023-10-16 3,282 2023-10-16 65,679,781    Premium*  
            Rapid Micro Biosystems, Inc. RPID 10% Owner 2021-07-19 0 2021-07-19 8,434,560    Premium*  
* Premium Members only  

Records found :    49         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 1 of 2
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
SLDB Solid Biosciences Inc   –       •       •   2024-01-11 4 A $5.53 $5,000,005 I/I 904,160 4,034,582 0 -
MRNS Marinus Pharmaceuticals I... 10% Owner   –       –       •   2017-12-15 4 S $8.02 $6,658,691 I/I (822,547) 4,427,453 0 -
MRNS Marinus Pharmaceuticals I... 10% Owner   –       –       •   2017-12-18 4 S $7.50 $2,251,440 I/I (300,000) 4,127,453 0 -
MRNS Marinus Pharmaceuticals I... 10% Owner   –       –       •   2017-12-19 4 S $7.11 $1,114,670 I/I (150,000) 3,977,453 0 -
SWTX Springworks Therapeutics,... 10% Owner   –       –       •   2019-09-17 4 A $0.00 $0 I/I 7,131,307 7,131,307 0 -
SWTX Springworks Therapeutics,... 10% Owner   –       –       •   2019-09-17 4 B $18.00 $2,700,000 I/I 150,000 7,281,307 1.5 -
SWTX Springworks Therapeutics,... 10% Owner   –       –       •   2021-03-09 4 S $71.50 $103,675,000 I/I (1,450,000) 5,831,307 0 -
RPID Rapid Micro Biosystems, I... 10% Owner   –       –       •   2021-07-19 4 A $0.00 $0 I/I 8,334,560 8,334,560 0 -
RPID Rapid Micro Biosystems, I... 10% Owner   –       –       •   2021-07-19 4 B $20.00 $2,000,000 I/I 100,000 8,434,560 1.5 %
SWTX Springworks Therapeutics,... 10% Owner   –       –       •   2021-08-10 4 S $70.25 $70,250,000 I/I (1,000,000) 4,831,307 0 -
PTCT PTC Therapeutics, Inc. Director   –       •      –    2013-06-25 4 B $15.00 $18,750,000 I/I 1,250,000 2,333,333 2.1 -
PTCT PTC Therapeutics, Inc. Director   –       •      –    2013-06-25 4 A $0.00 $0 I/I 1,083,333 1,083,333 0 -
DRNA Dicerna Pharmaceuticals I... Director   –       •       •   2017-12-18 4 A $0.00 $0 I/I 190,849 8,930,237 0 -
DRNA Dicerna Pharmaceuticals I... Director   –       •       •   2017-12-18 4 OE $0.00 $0 I/I 8,454,388 8,739,388 0 -
DRNA Dicerna Pharmaceuticals I... Director   –       •       •   2017-12-18 4 B $7.00 $1,995,000 I/I 285,000 285,000 2.25 -
SLDB Solid Biosciences Inc Director   –       •      –    2018-01-25 4 OE $0.00 $0 I/I 1,689,444 1,689,444 0 -
SLDB Solid Biosciences Inc Director   –       •      –    2018-01-30 4 B $16.00 $4,800,000 I/I 300,000 1,989,444 2.1 -
APTX Aptinyx Inc. Director   –       •      –    2018-06-25 4 A $0.00 $0 I/I 1,825,092 1,825,092 0 -
APTX Aptinyx Inc. Director   –       •      –    2018-06-25 4 B $16.00 $6,400,000 I/I 400,000 2,225,092 2.1 -
REPL Replimune Group Inc Director   –       •      –    2018-07-24 4 B $15.00 $7,500,000 I/I 500,000 2,838,968 2.1 -
REPL Replimune Group Inc Director   –       •      –    2018-07-24 4 A $0.00 $0 I/I 2,338,968 2,338,968 0 -
DRNA Dicerna Pharmaceuticals I... Director   –       •       •   2019-05-29 4 S $12.50 $20,000,000 I/I (1,600,000) 7,330,237 0 -
SLDB Solid Biosciences Inc Director   –       •      –    2019-07-30 4 A $4.65 $8,749,998 I/I 1,881,720 3,871,164 0 -
DRNA Dicerna Pharmaceuticals I... Director   –       •      –    2019-12-04 4 S $24.68 $37,020,000 I/I (1,500,000) 4,080,237 0 -
APTX Aptinyx Inc. Director   –       •       •   2020-01-14 4 B $3.00 $9,999,999 I/I 3,333,333 5,558,425 2.25 %
  49  Records found
  1  2      
  Page 1 of 2  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us